Profile | GDS5420 / 1563348_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 422.36 | 64 |
GSM1296119 | B_lesional_pre-dose | 238.11 | 55 |
GSM1296076 | C_lesional_pre-dose | 179.9 | 52 |
GSM1296092 | D_lesional_pre-dose | 173.43 | 52 |
GSM1296103 | E_lesional_pre-dose | 241.12 | 56 |
GSM1296078 | F_lesional_pre-dose | 231.76 | 56 |
GSM1296107 | G_lesional_pre-dose | 311.1 | 60 |
GSM1296109 | H_lesional_pre-dose | 238.92 | 54 |
GSM1296080 | I_lesional_pre-dose | 582.44 | 70 |
GSM1296090 | J_lesional_pre-dose | 139.77 | 48 |
GSM1296074 | K_lesional_pre-dose | 135.19 | 49 |
GSM1296111 | L_lesional_pre-dose | 183.79 | 50 |
GSM1296099 | M_lesional_pre-dose | 410.52 | 64 |
GSM1296086 | O_lesional_pre-dose | 199.46 | 54 |
GSM1296117 | P_lesional_pre-dose | 235.48 | 54 |
GSM1296113 | Q_lesional_pre-dose | 229.91 | 53 |
GSM1296096 | R_lesional_pre-dose | 303.1 | 59 |
GSM1296105 | S_lesional_pre-dose | 336.71 | 60 |
GSM1296098 | T_lesional_pre-dose | 458.34 | 66 |
GSM1296101 | U_lesional_pre-dose | 366.16 | 62 |
GSM1296121 | V_lesional_pre-dose | 296.74 | 59 |
GSM1296088 | W_lesional_pre-dose | 326.73 | 61 |
GSM1296082 | X_lesional_pre-dose | 197.26 | 54 |
GSM1296115 | Y_lesional_pre-dose | 273.32 | 57 |
GSM1296084 | Z_lesional_pre-dose | 306.1 | 59 |
GSM1296072 | B_lesional_day8 | 227.98 | 54 |
GSM1296069 | L_lesional_day8 | 218.17 | 52 |
GSM1296071 | P_lesional_day8 | 338.77 | 60 |
GSM1296070 | Y_lesional_day8 | 272.6 | 56 |
GSM1296073 | V_lesional_day8 | 216.44 | 54 |
GSM1296034 | A_lesional_day15 | 1192.15 | 82 |
GSM1296041 | G_lesional_day15 | 310.47 | 60 |
GSM1296035 | R_lesional_day15 | 184.77 | 51 |
GSM1296038 | U_lesional_day15 | 308.58 | 60 |
GSM1296047 | B_lesional_day15 | 333.2 | 60 |
GSM1296039 | E_lesional_day15 | 222.95 | 54 |
GSM1296042 | H_lesional_day15 | 327.92 | 60 |
GSM1296043 | L_lesional_day15 | 260.72 | 55 |
GSM1296037 | M_lesional_day15 | 429.76 | 65 |
GSM1296046 | P_lesional_day15 | 316.27 | 59 |
GSM1296044 | Q_lesional_day15 | 270.08 | 56 |
GSM1296045 | Y_lesional_day15 | 264.85 | 56 |
GSM1296025 | C_lesional_day15 | 645.99 | 72 |
GSM1296033 | D_lesional_day15 | 263.02 | 57 |
GSM1296027 | I_lesional_day15 | 341.34 | 62 |
GSM1296032 | J_lesional_day15 | 375.11 | 62 |
GSM1296024 | K_lesional_day15 | 594.81 | 71 |
GSM1296031 | W_lesional_day15 | 412.67 | 64 |
GSM1296028 | X_lesional_day15 | 404.07 | 64 |
GSM1296029 | Z_lesional_day15 | 367.26 | 62 |
GSM1296026 | F_lesional_day15 | 231.36 | 56 |
GSM1296030 | O_lesional_day15 | 188.75 | 53 |
GSM1296040 | S_lesional_day15 | 383.33 | 63 |
GSM1296036 | T_lesional_day15 | 504.67 | 67 |
GSM1296048 | V_lesional_day15 | 243.56 | 55 |
GSM1296059 | A_lesional_day43 | 332.52 | 61 |
GSM1296066 | G_lesional_day43 | 313.35 | 59 |
GSM1296060 | R_lesional_day43 | 292.77 | 58 |
GSM1296063 | U_lesional_day43 | 203.81 | 53 |
GSM1296064 | E_lesional_day43 | 299.18 | 60 |
GSM1296067 | H_lesional_day43 | 374.46 | 62 |
GSM1296062 | M_lesional_day43 | 417.51 | 64 |
GSM1296068 | Q_lesional_day43 | 203.34 | 50 |
GSM1296050 | C_lesional_day43 | 328.93 | 61 |
GSM1296057 | D_lesional_day43 | 205.51 | 53 |
GSM1296052 | I_lesional_day43 | 411.3 | 65 |
GSM1296054 | J_lesional_day43 | 508.34 | 67 |
GSM1296049 | K_lesional_day43 | 473.73 | 67 |
GSM1296055 | W_lesional_day43 | 256.12 | 56 |
GSM1296053 | X_lesional_day43 | 878.24 | 77 |
GSM1296058 | Z_lesional_day43 | 214.13 | 54 |
GSM1296051 | F_lesional_day43 | 264.73 | 58 |
GSM1296056 | O_lesional_day43 | 164.35 | 50 |
GSM1296065 | S_lesional_day43 | 295.81 | 59 |
GSM1296061 | T_lesional_day43 | 639.79 | 71 |
GSM1296095 | A_non-lesional_pre-dose | 417.33 | 65 |
GSM1296120 | B_non-lesional_pre-dose | 346.91 | 61 |
GSM1296077 | C_non-lesional_pre-dose | 412.55 | 65 |
GSM1296093 | D_non-lesional_pre-dose | 566.49 | 69 |
GSM1296104 | E_non-lesional_pre-dose | 277.22 | 58 |
GSM1296079 | F_non-lesional_pre-dose | 452.71 | 66 |
GSM1296108 | G_non-lesional_pre-dose | 375.25 | 63 |
GSM1296110 | H_non-lesional_pre-dose | 444.57 | 65 |
GSM1296081 | I_non-lesional_pre-dose | 1158.52 | 81 |
GSM1296091 | J_non-lesional_pre-dose | 199.65 | 53 |
GSM1296075 | K_non-lesional_pre-dose | 248.09 | 57 |
GSM1296112 | L_non-lesional_pre-dose | 318.06 | 59 |
GSM1296100 | M_non-lesional_pre-dose | 467.32 | 66 |
GSM1296087 | O_non-lesional_pre-dose | 205.24 | 55 |
GSM1296118 | P_non-lesional_pre-dose | 398.99 | 63 |
GSM1296114 | Q_non-lesional_pre-dose | 250.2 | 55 |
GSM1296097 | R_non-lesional_pre-dose | 373.84 | 63 |
GSM1296106 | S_non-lesional_pre-dose | 342.01 | 60 |
GSM1296102 | U_non-lesional_pre-dose | 478.14 | 66 |
GSM1296122 | V_non-lesional_pre-dose | 285.78 | 58 |
GSM1296089 | W_non-lesional_pre-dose | 388.38 | 63 |
GSM1296083 | X_non-lesional_pre-dose | 1250.6 | 83 |
GSM1296116 | Y_non-lesional_pre-dose | 383.23 | 62 |
GSM1296085 | Z_non-lesional_pre-dose | 449.14 | 66 |